John D. McKenzie
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
John D. McKenzie has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
- Claire Phillips
Department of Radiation Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia
2 shared publications - Lotte S. Fog
Australia and New Zealand Transplant and Cellular Therapies (ANZTCT) Sydney New South Wales Australia
2 shared publications - Roderick O'DAy
Ocular Oncology Research Unit, Centre for Eye Research Australia, Melbourne (Victoria), Australia; Department of Ocular Oncology, Royal Victorian Eye and Ear Hospital, Melbourne (Victoria), Australia roderick.o'
2 shared publications - Anthony Michael Joshua
Kinghorn Cancer Centre, St Vincent's Hospital Sydney Australia
1 shared publication Bertil E. Damato
Department of Ocular Oncology and NIHR Biomedical Research Centre for Ophthalmology at Moorfields Eye Hospital and UCL Institute of Ophthalmology, London, United Kingdom
1 shared publicationDamien Kee
Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne (Victoria), Australia; Department of Medical Oncology, Austin Health, Heidelberg (Victoria), Australia
1 shared publication
Latest Publications
- 26 May 2024
- Published by Elsevier in Canadian Journal of Ophthalmology
- Vol. 59 (5) , e525-e533
The Fight Tumour Blindness Registry: Efficient capture of high-quality real-world data in uveal melanoma
- 26 May 2024
- Published by Elsevier in Canadian Journal of Ophthalmology
- Vol. 59 (5) , e525-e533
The Fight Tumour Blindness Registry: Efficient capture of high-quality real-world data in uveal melanoma
- Open Access
- 4 April 2024
- Published by Elsevier in Canadian Journal of Ophthalmology
- Vol. 59 (6) , e775-e783
Apical dose versus volume dose of Ruthenium-106 brachytherapy for uveal melanoma
- 4 April 2024
- Published by Elsevier in Canadian Journal of Ophthalmology
- Vol. 59 (6) , e775-e783
Open AccessApical dose versus volume dose of Ruthenium-106 brachytherapy for uveal melanoma